miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma.
Leukemia
; 35(3): 823-834, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-32632096
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bone Neoplasms
/
Biomarkers, Tumor
/
T-Lymphocytes, Regulatory
/
MicroRNAs
/
Th17 Cells
/
Multiple Myeloma
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2021
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom